The clinical use of plasma clozapine levels in a maximum security setting

Daniel Mark Bennett, Margaret Bremner, Colin Gray

Research output: Contribution to journalArticlepeer-review


Background. Research suggests a correlation between clozapine dose, plasma level and therapeutic response. Plasma clozapine levels may, therefore, be useful in practice. Little evidence exists, however, on the indications for, and outcome of, levels being undertaken or their use in maximum security settings. Objective. To determine if plasma clozapine levels are useful in clinical practice by analysing their use at the maximum-security State Hospital, Carstairs. Methods. All plasma clozapine levels (until March 2004) undertaken at the State Hospital, clinical indication and outcome were analysed by retrospective case note analysis. These results were compared with the published literature. Results. A total of 140 plasma clozapine levels were analysed. The average level was 0.61 mg/l and dose was 622.9 mg/day. The indications for and consequences of levels are demonstrated. A positive correlation of 0.217 was calculated. Conclusion. This paper shows that plasma clozapine levels are most useful in managing side effects and suspected non-compliance. Plasma clozapine levels are, therefore, useful in clinical practice.

Original languageEnglish
Pages (from-to)228-234
Number of pages7
JournalInternational Journal of Psychiatry in Clinical Practice
Issue number3
Publication statusPublished - 2008


  • clozapine
  • maximum-security
  • plasma levels
  • clinical practice
  • clinical indications
  • compliance
  • schizophrenia
  • resistant


Dive into the research topics of 'The clinical use of plasma clozapine levels in a maximum security setting'. Together they form a unique fingerprint.

Cite this